April 11, 2022 Comments Off on New patent expiration for Boehringer Ingelheim drug SPIRIVA Posted in: Uncategorized
Annual Drug Patent Expirations for SPIRIVA Spiriva is a drug marketed by Boehringer Ingelheim and is included in two NDAs. It is available from two suppliers. There are sixteen patents…
The post New patent expiration for Boehringer Ingelheim drug SPIRI…
April 10, 2022 Comments Off on New patent expiration for Astellas drug LEXISCAN Posted in: Uncategorized
Annual Drug Patent Expirations for LEXISCAN Lexiscan is a drug marketed by Astellas and is included in one NDA. It is available from two suppliers. There are three patents protecting…
The post New patent expiration for Astellas drug LEXISCAN appeared f…